Allison Dorval is the chief financial officer at Verve Therapeutics. She has more than 25 years of leadership experience in finance, accounting and investor relations, including 15 in the life sciences industry. Prior to joining Verve, Allison served as chief financial officer at Voyager Therapeutics. She has also served as vice president and controller of Juniper Pharmaceuticals and as a consultant at Danforth Advisors. She has held several leadership roles at Insulet Corporation, including chief financial officer. Earlier in her career, she served in corporate finance positions with iBasis, Inc. and Digitas Inc. Allison is a member of the Board of Directors at Aerovate Therapeutics and Puma Biotechnology. 

Allison obtained a B.S. in Business Administration from the University of Vermont. She is a certified public accountant and began her career at PwC.